Literature DB >> 8196713

Pathogenesis of axonal Guillain-Barré syndrome: hypothesis.

N Yuki1.   

Abstract

Pathologic studies of acute motor axonal neuropathy show strong evidence of the presence of primary axonal Guillain-Barré syndrome (GBS). The pathogenesis of axonal GBS is speculated to be as follows: (1) Infection by an organism induces the high production of a cross-reactive antibody between an infectious agent and the motor nerve axon in patients with a particular immunogenetic background. (2) The antineural antibody binds to the motor nerve terminals, thereby inhibiting motoneuron excitability and causing muscular weakness. (3) Binding of the antineural antibody, or subsequent functional impairment of the motoneurons, causes the motor axon to degenerate from the terminals. (4) In severe cases, extensive axonal loss and central chromatolysis of the motoneurons occur. These inhibit recovery and lead to a poor functional prognosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196713     DOI: 10.1002/mus.880170619

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.

Authors:  Ruprecht Schmidt-Ott; Holger Schmidt; Sylvia Feldmann; Felicitas Brass; Bernd Krone; Uwe Gross
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.

Authors:  M M Prendergast; T U Kosunen; A P Moran
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

3.  Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.

Authors:  D A Sack; A J Lastovica; S H Chang; G Pazzaglia
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

4.  Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.

Authors:  M M Prendergast; A J Lastovica; A P Moran
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 5.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Immunoreactivity of glycoproteins isolated from human peripheral nerve and Campylobacter jejuni (O:19).

Authors:  Katerina Brezovska; Ana Poceva Panovska; Aleksandra Grozdanova; Ljubica Suturkova; Ivana Basta; Slobodan Apostolski
Journal:  J Neurosci Rural Pract       Date:  2011-07

Review 7.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

Review 8.  Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.

Authors:  Nobuhiro Yuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.